Assetmark, Inc Gsk PLC Transaction History

Assetmark, Inc

  • $34.9 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
BUY
$42.05 - $47.77 $121,608 - $138,150
2,892 Added 42.79%
9,650 $420,000
Q1 2022

May 13, 2022
BUY
$40.23 - $47.74 $99,126 - $117,631
2,464 Added 57.38%
6,758 $294,000
Q4 2021

Feb 14, 2022
BUY
$38.88 - $45.31 $25,660 - $29,904
660 Added 18.16%
4,294 $189,000
Q3 2021

Nov 12, 2021
SELL
$38.79 - $43.16 $178,821 - $198,967
-4,610 Reduced 55.92%
3,634 $139,000
Q2 2021

Aug 16, 2021
SELL
$36.52 - $41.46 $1.34 Million - $1.52 Million
-36,710 Reduced 81.66%
8,244 $328,000
Q1 2021

May 14, 2021
SELL
$34.27 - $40.01 $4.42 Million - $5.16 Million
-128,920 Reduced 74.15%
44,954 $1.6 Million
Q4 2020

Feb 10, 2021
BUY
$34.07 - $39.94 $219,478 - $257,293
6,442 Added 3.85%
173,874 $6.4 Million
Q3 2020

Nov 13, 2020
BUY
$38.11 - $42.99 $320,238 - $361,244
8,403 Added 5.28%
167,432 $6.3 Million
Q2 2020

Aug 11, 2020
BUY
$37.87 - $43.58 $546,729 - $629,164
14,437 Added 9.98%
159,029 $6.49 Million
Q1 2020

May 12, 2020
SELL
$32.47 - $48.83 $83,447 - $125,493
-2,570 Reduced 1.75%
144,592 $5.48 Million
Q4 2019

Feb 11, 2020
BUY
$42.0 - $48.25 $5.86 Million - $6.74 Million
139,628 Added 1853.31%
147,162 $6.92 Million
Q3 2019

Nov 13, 2019
BUY
$40.46 - $43.52 $13,189 - $14,187
326 Added 4.52%
7,534 $322,000
Q2 2019

Aug 14, 2019
BUY
$39.4 - $42.7 $141,288 - $153,122
3,586 Added 99.01%
7,208 $288,000
Q1 2019

May 14, 2019
SELL
$38.57 - $42.69 $1,967 - $2,177
-51 Reduced 1.39%
3,622 $151,000
Q4 2018

Feb 13, 2019
BUY
$37.8 - $42.69 $121,186 - $136,864
3,206 Added 686.51%
3,673 $140,000
Q3 2018

Nov 13, 2018
BUY
$39.75 - $42.69 $2,544 - $2,732
64 Added 15.88%
467 $19,000
Q2 2018

Aug 01, 2018
BUY
$39.61 - $42.76 $356 - $384
9 Added 2.28%
403 $16,000
Q1 2018

May 16, 2018
SELL
$36.18 - $40.15 $7,308 - $8,110
-202 Reduced 33.89%
394 $15,000
Q4 2017

Feb 13, 2018
BUY
$35.34 - $41.9 $1,342 - $1,592
38 Added 6.81%
596 $21,000
Q3 2017

Nov 08, 2017
SELL
$39.44 - $41.55 $5.44 Million - $5.73 Million
-137,950 Reduced 99.6%
558 $23,000
Q2 2017

Aug 15, 2017
SELL
N/A
-42,071 Reduced 23.3%
138,508 $5.97 Million
Q1 2017

Sep 15, 2017
BUY
N/A
3,012 Added 1.7%
180,579 $7.61 Million
Q4 2016

Sep 15, 2017
BUY
N/A
15,642 Added 9.66%
177,567 $6.84 Million
Q3 2016

Sep 15, 2017
SELL
N/A
-139,412 Reduced 46.26%
161,925 $6.98 Million
Q2 2016

Sep 15, 2017
BUY
N/A
14,634 Added 5.1%
301,337 $13.1 Million
Q1 2016

Sep 15, 2017
BUY
N/A
39,122 Added 15.8%
286,703 $11.6 Million
Q4 2015

Sep 15, 2017
BUY
N/A
247,581
247,581 $9.99 Million

Others Institutions Holding GSK

# of Institutions
20
Shares Held
176K
Call Options Held
0
Put Options Held
0
View Full List

About GSK PLC

GSK Quotes by TradingView
  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email